The interleukin 1 receptor family

Developmental and Comparative Immunology

Volumn 28, Issue 5, 2004, Pages 415-428

  Subramaniam, Sumathi ^a   Stansberg, Christine ^a   Cunningham, Charles ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cytokine; Interleukin 1; Interleukin 1 receptor; Toll; Toll like receptor

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; TOLL LIKE RECEPTOR;

GENOME; HUMAN; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0842346196     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2003.09.016     Document Type: Article

References (142)

1. Bowie A., O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leuk Biol. 67:2000;508-514.
2. Mitcham J.L., Parnet P., Bonnert T.P., et al. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem. 271:1996;5777-5783.
3. O'Neill L.A., Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leuk Biol. 63:1998;650-657.
4. Fallon P.G., Allen R.L., Rich T. Primitive Toll signaling: bugs, flies, worms and man. Trends Immunol. 22:2001;63-66.
5. Gay N.J., Keith F.J. Drosophila Toll and IL-1 receptor. Nature. 351:1991;355-356.
6. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA. 95:1998;588-593.
7. Stock J., Levit M. Signal transduction: hair brains in bacterial chemotaxis. Curr Biol. 10:2000;R11-R14.
8. Xu Y., Tao X., Shen B., et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 408:2000;111-115.
9. Burns K., Martinon F., Esslinger C., et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 273:1998;12203-12209.
10. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:1997;837-847.
11. O'Neill L.A., Dinarello C.A. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defence. Immunol Today. 21:2000;206-209.
12. Heguy A., Baldari C.T., Macchia G., Telford J.L., Melli M. Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction. J Biol Chem. 267:1992;2605-2609.
13. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
14. Slack J.L., Schooley K., Bonnert T.P., et al. Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J Biol Chem. 275:2000;4670-4678.
15. Radons J., Gabler S., Wesche H., Korherr C., Hofmeister R., Falk W. Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling. J Biol Chem. 277:2002;16456-16463.
16. Kuno K., Okamoto S., Hirose K., Murakami S., Matsushima K. Structure and function of the intracellular portion of the mouse interleukin 1 receptor (type I). Determining the essential region for transducing signals to activate the interleukin 8 gene. J Biol Chem. 268:1993;13510-13518.
17. Croston G.E., Cao Z., Goeddel D.V. NF-kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J Biol Chem. 270:1995;16514-16517.
18. Du X., Poltorak A., Wei Y., Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw. 11:2000;362-371.
19. Dale M., Nicklin M.J. Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1R-rp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics. 57:1999;177-179.
20. Barton J.L., Herbst R., Bosisio D., Higgins L., Nicklin M.J. A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities. Eur J Immunol. 30:2000;3299-3308.
21. Smith D.E., Renshaw B.R., Ketchem R.R., Kubin M., Garka K.E., Sims J.E. Four new members expand the interleukin-1 superfamily. J Biol Chem. 275:2000;1169-1175.
22. Dale M., Hammond D.W., Cox A., Nicklin M.J. The human gene encoding the interleukin-1 receptor accessory protein (IL1RAP) maps to chromosome 3q28 by fluorescence in situ hybridization and radiation hybrid mapping. Genomics. 47:1998;325-326.
23. Thomassen E., Renshaw B.R., Sims J.E. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine. 11:1999;389-399.
24. Born T.L., Smith D.E., Garka K.E., Renshaw B.R., Bertles J.S., Sims J.E. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem. 275:2000;29946-29954.
25. Dinarello C.A. The biology of interleukin-1. Chem Immunol. 51:1992;1-32.
26. Dinarello C.A. Role of interleukin-1 in infectious disease. Immunol Revi. 127:1992;119-146.
27. Dinarello C.A. The role of interleukin-1 in host responses to infectious diseases. Infect Agents Dis. 1:1992;227-236.
28. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 16:1998;457-499.
29. Dinarello C.A. Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol. 216:1996;133-136.
30. Dinarello C.A. Thermoregulation and the pathogenesis of fever. Infect Dis Clin North Am. 10:1996;433-449.
31. Mizel S.B. The interleukins. FASEB J. 3:1989;2379-2388.
32. Krueger J.M., Walter J., Dinarello C.A., Wolff S.M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol. 246:1984;R994-R999.
33. McCarthy D.O., Kluger M.J., Vander A.J. Suppression of food intake during infection: is interleukin-1 involved? Am J Clin Nutr. 42:1985;1179-1182.
34. Berkenbosch F., de Goeij D.E., Rey A.D., Besedovsky H.O. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology. 50:1989;570-576.
35. Loddick S.A., Liu C., Takao T., Hashimoto K., De Souza E.B. Interleukin-1 receptors: cloning studies and role in central nervous system disorders. Brain Res Brain Res Rev. 26:1998;306-319.
36. Sims J.E., March C.J., Cosman D., et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 241:1988;585-589.
37. Sims J.E., Acres R.B., Grubin C.E., et al. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci USA. 86:1989;8946-8950.
38. Dower S.K., Kronheim S.R., March C.J., et al. Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med. 162:1985;501-515.
39. Auron P.E. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:1998;221-237.
40. Sims J.E., Dower S.K. Interleukin-1 receptors. Eur Cytokine Netw. 5:1994;539-546.
41. Einstein R., et al. Type I IL-1 receptor: ligand specific confirmation differences and the role of glycosylation in ligand binding. Cytokine. 8:1996;206-213.
42. Vigers G.P., Anderson L.J., Caffes P., Brandhuber B.J. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature. 386:1997;190-194.
43. Martin M., Resch K. Interleukin 1: more than a mediator between leukocytes. Trends Pharmacol Sci. 9:1988;171-177.
44. Osborn L., Kunkel S., Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA. 86:1989;2336-2340.
45. Pruitt J.H., Welborn M.B., Edwards P.D., et al. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood. 87:1996;3282-3288.
46. Arend W.P., Malyak M., Smith M.F. Jr, et al. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol. 153:1994;4766-4774.
47. Fernandez-Botran R., Chilton P.M., Ma Y. Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv Immunol. 63:1996;269-336.
48. Ghivizzani S.C., Lechman E.R., Kang R., et al. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA. 95:1998;4613-4613.
49. Preas H.L. II, Reda D., Tropea M., et al. Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin. Blood. 88:1996;2465-2472.
50. Sporri B., Wiesmann U.N., Ochsenbein R.M., et al. Soluble IL-1 receptor type I binds to human dermal fibroblasts and induces calcium flux. FEBS Lett. 434:1998;283-288.
51. Sims J.E., Painter S.L., Gow I.R. Genomic organization of the type I and type II IL-1 receptors. Cytokine. 7:1995;483-490.
52. Subramaniam S., Stansberg C., Olsen L., Zou J., Secombes C.J., Cunningham C. Cloning of a Salmo salar interleukin-1 receptor-like cDNA. Dev Comp Immunol. 26:2002;415-431.
53. McMahan C.J., Slack J.L., Mosley B., et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
54. Colotta F., Re F., Muzio M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
55. Colotta F., Dower S.K., Sims J.E., Mantovani A. The type II decoy receptor: a novel regulatory pathway for interleukin 1. Immunol Today. 15:1994;562-566.
56. Symons J.A., Young P.R., Duff G.W. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci USA. 92:1995;1714-1718.
57. Kollewe C., Neumann D., Martin M.U. The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1beta. FEBS Lett. 487:2000;189-193.
58. Lang D., Knop J., Wesche H., et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol. 161:1998;6871-6877.
59. Malinowsky D., Lundkvist J., Laye S., Bartfai T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429:1998;299-302.
60. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem. 270:1995;13757-13765.
61. Wesche H., Resch K., Martin M.U. Effects of IL-1 receptor accessory protein on IL-1 binding. FEBS Lett. 429:1998;303-306.
62. Cullinan E.B., Kwee L., Nunes P., et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol. 161:1998;5614-5620.
63. Wesche H., Korherr C., Kracht M., Falk W., Resch K., Martin M.U. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem. 272:1997;7727-7731.
64. Huang J., Gao X., Li S., Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA. 94:1997;12829-12832.
65. Casadio R., Frigimelica E., Bossu P., et al. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett. 499:2001;65-68.
66. Jensen L.E., Muzio M., Mantovani A., Whitehead A.S. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol. 164:2000;5277-5286.
67. Lovenberg T.W., Crowe P.D., Liu C., et al. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). J Neuroimmunol. 70:1996;113-122.
68. Debets R., Timans J.C., Homey B., et al. Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol. 167:2001;1440-1446.
69. Carrie A., Jun L., Bienvenu T., et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet. 23:1999;25-31.
70. Jin H., Gardner R.J., Viswesvaraiah R., Muntoni F., Roberts R.G. Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.1-Xp21.3 mental retardation. Eur J Hum Genet. 8:2000;87-94.
71. Liu C., Chalmers D., Maki R., De Souza E.B. Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J Neuroimmunol. 66:1996;41-48.
72. Sana T.R., Debets R., Timans J.C., Bazan J.F., Kastelein R.A. Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3. Genomics. 69:2000;252-262.
73. Norris J.L., Manley J.L. Regulation of dorsal in cultured cells by Toll and tube: tube function involves a novel mechanism. Genes Dev. 9:1995;358-369.
74. Dunn E., Sims J.E., Nicklin M.J., O'Neill L.A. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol. 22:2001;533-536.
75. Kumar S., McDonnell P.C., Lehr R., et al. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem. 275:2000;10308-10314.
76. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol. 12:2000;59-63.
77. Bazan J.F., Timans J.C., Kastelein R.A. A newly defined interleukin-1? Nature. 379:1996;591.
78. Torigoe K., et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem. 272:1997;25737-25742.
79. Parnet P., Garka K.E., Bonnert T.P., Dower S.K., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem. 271:1996;3967-3970.
80. Okamura H., Tsutsi H., Komatsu T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 378:1995;88-91.
81. Born T.L., Thomassen E., Bird T.A., Sims J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem. 273:1998;29445-29450.
82. Novick D., Kim S.H., Fantuzzi G., et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 10:1999;127-136.
83. Pan G., Risser P., Mao W., et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine. 13:2001;1-7.
84. Klemenz R., Hoffmann S., Jaggi R., Werenskiold A.K. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis. Oncogene. 4:1989;799-803.
85. Tominaga S., Jenkins N.A., Gilbert D.J., Copeland N.G., Tetsuka T. Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim Biophys Acta. 1090:1991;1-8.
86. Lanahan A., Williams J.B., Sanders L.K., Nathans D. Growth factor-induced delayed early response genes. Mol Cell Biol. 12:1992;3919-3929.
87. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13:1994;1176-1188.
88. Li H., Tago K., Io K., et al. The cloning and nucleotide sequence of human ST2L cDNA. Genomics. 67:2000;284-290.
89. Tominaga S., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Komatsu N. Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem Biophys Res Commun. 264:1999;14-18.
90. Gachter T., Werenskiold A.K., Klemenz R. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J Biol Chem. 271:1996;124-129.
91. Iwahana H., Yanagisawa K., Ito-Kosaka A., et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem. 264:1999;397-406.
92. Gayle M.A., Slack J.L., Bonnert T.P., et al. Cloning of a putative ligand for the T1/ST2 receptor. J Biol Chem. 271:1996;5784-5789.
93. Kumar S., Minnich M.D., Young P.R. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem. 270:1995;27905-27913.
94. Lohning M., Stroehmann A., Coyle A.J., et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA. 95:1998;6930-6935.
95. Carter R.W., Sweet M.J., Xu D., Klemenz R., Liew F.Y., Chan W.L. Regulation of ST2L expression on T helper (Th) type 2 cells. Eur J Immunol. 31:2001;2979-2985.
96. Senn K.A., McCoy K.D., Maloy K.J., et al. T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2- type immune response following infection with Nippostrongylus brasiliensis. Eur J Immunol. 30:2000;1929-1938.
97. Hoshino K., Kashiwamura S., Kuribayashi K., et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med. 190:1999;1541-1548.
98. Coyle A.J., Lloyd C., Tian J., et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med. 190:1999;895-902.
99. Walzl G., Matthews S., Kendall S., et al. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med. 193:2001;785-792.
100. Fitzgerald K.A., O'Neill L.A. The role of the interleukin-1/Toll-like receptor superfamily in inflammation and host defence. Microbes Infect. 2:2000;933-943.
101. Frantz S., Kelly R.A., Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem. 276:2001;5197-5203.
102. Hayashi F., Smith K.D., Ozinsky A., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 410:2001;1099-1103.
103. Hemmi H., Takeuchi O., Kawai T., et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
104. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor- associated factor 6 (TRAF6). J Exp Med. 187:1998;2097-2101.
105. Xu Y., Tao X., Shen B., et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 408:2000;111-115.
106. Burns K., Clatworthy J., Martin L., et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol. 2:2000;346-351.
107. Medzhitov R., Preston-Hurlburt P., Kopp E., et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 2:1998;253-258.
108. Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL- 1 signaling. Science. 278:1997;1612-1615.
109. Cao Z., Henzel W.J., Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1996;1128-1131.
110. Wesche H., Gao X., Li X., Kirschning C.J., Stark G.R., Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem. 274:1999;19403-19410.
111. Bulut Y., Faure E., Thomas L., Equils O., Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol. 167:2001;987-994.
112. Takatsuna H., Kato H., Gohda J., et al. Identification of TIFA as an adapter protein that links TRAF6 to IRAK-1 in IL-1 receptor signaling. J Biol Chem. 278:2003;12144-12150.
113. Jiang Z., Johnson H.J., Nie H., Qin J., Bird T.A., Li X. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem. 278:2003;10952-10956.
114. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K., et al. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature. 398:1999;252-256.
115. Martin M.U., Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta. 1592:2002;265-280.
116. Kopp E., Medzhitov R., Carothers J., et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13:1999;2059-2071.
117. Leonardi A., Ellinger-Ziegelbauer H., Franzoso G., Brown K., Siebenlist U. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. J Biol Chem. 275:2000;271-278.
118. Jefferies C.A., O'Neill L.A. Rac1 regulates interleukin 1-induced nuclear factor kappaB activation in an inhibitory protein kappaBalpha- independent manner by enhancing the ability of the p65 subunit to transactivate gene expression. J Biol Chem. 275:2000;3114-3120.
119. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol. 167:2001;1882-1885.
120. Janssens S., Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci. 27:2002;474-482.
121. Lomaga M.A., Yeh W.C., Sarosi I., et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
122. Jensen L.E., Whitehead A.S. IRAK1b, a novel alternative splice variant of interleukin-1 receptor- associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J Biol Chem. 276:2001;29037-29044.
123. Suzuki N., Suzuki S., Yeh W.C. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol. 23:2002;503-506.
124. Li S., Strelow A., Fontana E.J., Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA. 99:2002;5567-5572.
125. Yamin T.T., Miller D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J Biol Chem. 272:1997;21540-21547.
126. Hulbert S.H., Webb C.A., Smith S.M., Sun Q. Resistance gene complexes: evolution and utilization. Annu Rev Phytopathol. 39:2001;285-312.
127. Anderson K.V., Bokla L., Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell. 42:1985;791-798.
128. Anderson K.V., Jurgens G., Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell. 42:1985;779-789.
129. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
130. Johnson G.B., Brunn G.J., Tang A.H., Platt J.L. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol. 24:2003;19-24.
131. Kimbrell D.A., Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet. 2:2001;256-267.
132. Luo C., Zheng L. Independent evolution of Toll and related genes in insects and mammals. Immunogenetics. 51:2000;92-98.
133. Weining K.C., Sick C., Kaspers B., Staeheli P. A chicken homolog of mammalian interleukin-1 beta: cDNA cloning and purification of active recombinant protein. Eur J Biochem. 258:1998;994-1000.
134. Zou J., Bird S., Minter R., Horton J., Cunningham C., Secombes C.J., et al. Molecular cloning of the gene for interleukin-1beta from Xenopus laevis and analysis of expression in vivo and in vitro. Immunogenetics. 51:2000;332-338.
135. Zou J., Grabowski P.S., Cunningham C., Secombes C.J. Molecular cloning of interleukin 1beta from rainbow trout Oncorhynchus mykiss reveals no evidence of an ice cut site. Cytokine. 11:1999;552-560.
136. Bird S., Wang T., Zou J., Cunningham C., Secombes C.J. The first cytokine sequence within cartilaginous fish: IL-1 beta in the small spotted catshark (Scyliorhinus canicula). J Immunol. 168:2002;3329-3340.
137. Guida S., Heguy A., Melli M. The chicken IL-1 receptor: differential evolution of the cytoplasmic and extracellular domains. Gene. 111:1992;239-243.
138. Sangrador-Vegas A., Martin S.A., O'Dea P.G., Smith T.J. Cloning and characterization of the rainbow trout (Oncorhynchus mykiss) type II interleukin-1 receptor cDNA. Eur J Biochem. 267:2000;7031-7037.
139. Ottaviani E., Franchini A., Cassanelli S., Genedani S. Cytokines and invertebrate immune responses. Biol Cell. 85:1995;87-91.
140. Beck G., Ellis T.W., Truong N. Characterization of an IL-1 receptor from Asterias forbesi coelomocytes. Cell Immunol. 203:2000;66-73.
141. McMahan C.J., Slack J.L., Mosley B. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
142. Pujol N., Link E.M., Liu L.X., et al. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr Biol. 11:2001;809-821.